Jun 24 |
Avalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officer
|
Jun 17 |
Avalo to Present at the Oppenheimer Novel Targets in Immunology Summit
|
Jun 6 |
Avalo Therapeutics files to sell 22.36M shares for holders
|
May 13 |
Avalo Therapeutics reports Q1 results
|
May 13 |
Avalo Reports First Quarter 2024 Financial Results and Provides Business Updates
|
Apr 2 |
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Apr 2 |
Avalo Therapeutics Appoints Biotech Leaders to Board of Directors
|
Apr 1 |
Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket
|
Apr 1 |
Avalo Therapeutics EPS of -$114.00, revenue of $1.92M beats by $0.72M
|
Mar 29 |
Avalo Reports 2023 Financial Results and Provides Business Updates
|